Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 27235919 | HLA MATCHED (HLA-MATCHED) | disorders chromosomal | NA | NA | NA | unclassified | |
| the indications of pgt include identification of embryos harboring single-gene disorders, chromosomal structural abnormalities, chromosomal numeric abnormalities, and mitochondrial disorders; gender selection; and identifying unaffected, hla-matched embryos to permit the creation of a savior sibling. | |||||||
| 27235919 | HLA MATCHED (HLA-MATCHED) | mitochondrial disorders | NA | NA | NA | unclassified | |
| the indications of pgt include identification of embryos harboring single-gene disorders, chromosomal structural abnormalities, chromosomal numeric abnormalities, and mitochondrial disorders; gender selection; and identifying unaffected, hla-matched embryos to permit the creation of a savior sibling. | |||||||
| 23555373 | HLA (HLA) | deep vein thrombosis | NA | NA | NA | unclassified | |
| in addition, both a female predominance and an association of hla with cteph unrelated to deep vein thrombosis are observed in japan, thus suggesting this condition to be a type of pulmonary vasculopathy. | |||||||
| 23978639 | HLA-B*52 | deep vein thrombosis | Japanese | riociguat | NA | unclassified | |
| a japanese multicenter study reported that a form of cteph unrelated to deep vein thrombosis is associated with hla-b*5201, suggesting that this form of cteph may be associated with vasculopathy. | |||||||
| 27263776 | HLA (HLA) | hemophagocytic syndrome | Japanese | busulfan | NA | unclassified | |
| first, several mechanisms of engraftment failure following cbt other than cell dose have been reported, such as the presence of donor-specific anti-hla antibodies or the development of hemophagocytic syndrome. | |||||||
| 16301628 | HLA-DR (HLA-DR) | anthrax | NA | NA | NA | unclassified | |
| although the plague vaccine is equivalent to control maturation factors in maturation and stimulation of dcs and induces strong mlr and th outgrowth, the anthrax vaccine is a poor inducer of dc maturation, as indicated by low levels of hla-dr, cd86, and cd83 induction and minimal proinflammatory cytokine production. | |||||||
| 16301628 | HLA-DR (HLA-DR) | plague | NA | NA | NA | unclassified | |
| although the plague vaccine is equivalent to control maturation factors in maturation and stimulation of dcs and induces strong mlr and th outgrowth, the anthrax vaccine is a poor inducer of dc maturation, as indicated by low levels of hla-dr, cd86, and cd83 induction and minimal proinflammatory cytokine production. | |||||||
| 17283103 | MHC (MHC) | anthrax | NA | NA | NA | unclassified | |
| we have used soluble peptide-mhc class ii tetramers containing peptides from the protective antigen (pa) of bacillus anthracis to detect circulating t cells in peripheral blood of subjects vaccinated with an anthrax vaccine. | |||||||
| 20208010 | HLA (HLA) | anthrax | NA | NA | NA | positive | |
| some of these anthrax epitopes showed broad binding to several hla class alleles, but others were more constrained in their hla binding patterns. | |||||||
| 21368772 | DR-DQ (HAPLOTYPE) | anthrax | African American | NA | NA | unclassified | |
| the role of hla-dr-dq haplotypes in variable antibody responses to anthrax vaccine adsorbed. | |||||||
Copyright 2024